-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
medsci.
medsci.
The researchers retrospectively included patients with ulcerative colitis with generalized colitis in clinical remission and followed up for a period of 2 years.
A total of 91 CER patients and 54 SS patients were included in this study, and 63 relapses (47 mild and 16 severe) occurred in the end.
Figure: The incidence of mild recurrence of distal colon tissue was significantly higher than that of the complete healing group under endoscopy
Therefore, the author concludes that as long as endoscopic remission is obtained in the proximal colon, residual distal colon inflammation is not a major risk factor for recurrence.
Therefore, the author concludes that as long as endoscopic remission is obtained in the proximal colon, residual distal colon inflammation is not a major risk factor for recurrence.
Original source:
Kunio Asonuma.
oup.
com/ibdjournal/advance-article-abstract/doi/10.
1093/ibd/izab062/6224886?redirectedFrom=fulltext" target="_blank" rel="noopener">Residual Short-Segment Distal Inflammation Has No Significant Impact on the Major Relapse of Extensive Ulcerative Colitis.
Leave a message here